About this trial
The goal of this clinical trial is to examine if non-invasive brain stimulation (NIBS) can enhance cognitive function with chronic obstructive pulmonary disease (COPD) population. The main questions it aims to answer are:
* What is the possibility effect of using the NIBS on cognitive functions as well as the cardiopulmonary parameters in COPD population? * What is the relation between cognitive function parameters and cardiopulmonary parameters in COPD population who suffer from cognitive impairment (CI)? Researchers will compare NIBS to a sham-NIBS to see if NIBS works to improve cognitive function in COPD population.
Participants will:
Receive NIBS or a sham-NIBS 5 sessions/week for 3 weeks for 20 min each session.
Visit the clinic at the beginning for baseline assessment then after the completion of the 3 weeks to reassess them.
Outcome measures for cognitive parameters and pulmonary parameters will be taken pre and post NIBS intervention
Eligibility criteria
Qualifiers
Adult age from eighteen years old and above.
Patients with confirmed COPD via pulmonary function test (PFT) according to the classifications of GOLD.
All stages of GOLD will be included
Stable patients, which means they were not admitted to the hospital in the last 3 months
Disqualifiers
Patients without COPD
Unstable patients with several admission in the last 3 months
Patients with COPD but without cognitive impairment.
COPD patients who suffered from any neurological problems
Trial design
Treatments tested in this trial
- Non-invasive brain stimulation
- Sham Non-Invasive brain stimulation
Treatment groups
Sponsors and collaborators
Shahad Abdulrahman Alkandari
Lead sponsor
Ministry of Health, Kuwait
Sponsor institution
Imam Abdulrahman Bin Faisal University
Collaborator